These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 19142878

  • 1. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis.
    Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS, Urologic Diseases in America Project.
    Cancer; 2009 Mar 01; 115(5):988-96. PubMed ID: 19142878
    [Abstract] [Full Text] [Related]

  • 2. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
    Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I.
    J Urol; 2013 Jul 01; 190(1):55-60. PubMed ID: 23313198
    [Abstract] [Full Text] [Related]

  • 3. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
    Schiffmann J, Gandaglia G, Larcher A, Sun M, Tian Z, Shariat SF, McCormack M, Valiquette L, Montorsi F, Graefen M, Saad F, Karakiewicz PI.
    Eur J Surg Oncol; 2014 Dec 01; 40(12):1738-45. PubMed ID: 25454826
    [Abstract] [Full Text] [Related]

  • 4. Use of radical cystectomy for patients with invasive bladder cancer.
    Gore JL, Litwin MS, Lai J, Yano EM, Madison R, Setodji C, Adams JL, Saigal CS, Urologic Diseases in America Project.
    J Natl Cancer Inst; 2010 Jun 02; 102(11):802-11. PubMed ID: 20400716
    [Abstract] [Full Text] [Related]

  • 5. Treatment delay and prognosis in invasive bladder cancer.
    Liedberg F, Anderson H, Månsson W.
    J Urol; 2005 Nov 02; 174(5):1777-81; discussion 1781. PubMed ID: 16217282
    [Abstract] [Full Text] [Related]

  • 6. Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.
    Bekelman JE, Handorf EA, Guzzo T, Evan Pollack C, Christodouleas J, Resnick MJ, Swisher-McClure S, Vaughn D, Ten Have T, Polsky D, Mitra N.
    Value Health; 2013 Jun 02; 16(4):610-8. PubMed ID: 23796296
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
    Ge P, Wang ZC, Yu X, Lin J, He Q.
    BMC Urol; 2015 May 30; 15():46. PubMed ID: 26025446
    [Abstract] [Full Text] [Related]

  • 8. "Real-world" outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma.
    Drakaki A, Pantuck A, Mhatre SK, Dhillon PK, Davarpanah N, Degaonkar V, Surinach A, Chamie K, Grivas P.
    Urol Oncol; 2021 Jan 30; 39(1):76.e15-76.e22. PubMed ID: 32778476
    [Abstract] [Full Text] [Related]

  • 9. Volume outcomes of cystectomy--is it the surgeon or the setting?
    Morgan TM, Barocas DA, Keegan KA, Cookson MS, Chang SS, Ni S, Clark PE, Smith JA, Penson DF.
    J Urol; 2012 Dec 30; 188(6):2139-44. PubMed ID: 23083864
    [Abstract] [Full Text] [Related]

  • 10. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, Senagore AJ, Orihuela E, Tyler DS, Swanson TA, Kamat AM.
    JAMA Surg; 2018 Oct 01; 153(10):881-889. PubMed ID: 29955780
    [Abstract] [Full Text] [Related]

  • 11. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
    Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, Herr HW, Bochner BH.
    Cancer; 2008 Jun 01; 112(11):2384-92. PubMed ID: 18404699
    [Abstract] [Full Text] [Related]

  • 12. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec 01; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 13. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M, Helke C, Nitzke T, Vogler H, Hoschke B.
    Urol Int; 2004 Dec 01; 72(2):103-11. PubMed ID: 14963349
    [Abstract] [Full Text] [Related]

  • 14. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma.
    Sánchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB.
    J Urol; 2003 Jan 01; 169(1):110-5; discussion 115. PubMed ID: 12478115
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul 01; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.
    Audenet F, Waingankar N, Ferket BS, Niglio SA, Marqueen KE, Sfakianos JP, Galsky MD.
    J Urol; 2018 Nov 01; 200(5):996-1004. PubMed ID: 29879397
    [Abstract] [Full Text] [Related]

  • 17. Urethrectomy following cystectomy for bladder cancer in men: practice patterns and impact on survival.
    Nelles JL, Konety BR, Saigal C, Pace J, Lai J, Urologic Diseases in America Project.
    J Urol; 2008 Nov 01; 180(5):1933-6; discussion 1936-7. PubMed ID: 18801516
    [Abstract] [Full Text] [Related]

  • 18. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cahn DB, Handorf EA, Ghiraldi EM, Ristau BT, Geynisman DM, Churilla TM, Horwitz EM, Sobczak ML, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG, Smaldone MC.
    Cancer; 2017 Nov 15; 123(22):4337-4345. PubMed ID: 28743162
    [Abstract] [Full Text] [Related]

  • 19. Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
    Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes JA, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Sylvester R.
    World J Urol; 2018 Nov 15; 36(11):1775-1781. PubMed ID: 30171454
    [Abstract] [Full Text] [Related]

  • 20. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD, Logan JE, Sills V, Chin AI.
    World J Urol; 2014 Apr 15; 32(2):385-91. PubMed ID: 23756991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.